C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2007
11/21/2007	EP1856157A2 Treatment of bone disorders
11/21/2007	EP1856156A2 Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation
11/21/2007	EP1856155A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/21/2007	EP1856154A1 Humanized anti-ghrelin antibodies
11/21/2007	EP1856153A1 Ykl-40 monoclonal antibodies
11/21/2007	EP1856148A1 Neuropeptides
11/21/2007	EP1855717A1 Surface-located streptococcus pneumoniae polypeptides
11/21/2007	EP1651955A4 Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials
11/21/2007	EP1525223B1 Ox40 (=cd134) receptor agonists and therapeutic use
11/21/2007	EP1414492B1 Method for treating multiple myeloma
11/21/2007	EP1395830B1 Bcmp-101, a cancer associated protein
11/21/2007	EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007	EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007	EP0904378B1 Hepatitis b monoclonal antibodies
11/21/2007	CN101076730A Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
11/21/2007	CN101076543A Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease
11/21/2007	CN101076542A Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof
11/21/2007	CN101074265A Recombinant anti-TNFR monoclonal antibody, its production and use
11/21/2007	CN101074264A Recombinant anti-CTLA4 monoclonal antibody, its production and use
11/21/2007	CN101074263A Recombinant proteinA monoclonal antibody, its production and use
11/21/2007	CN101074262A Recombinant anti-FL moncclonal antibody, its production and use
11/21/2007	CN101074261A TRAIL receptor I and/or TRAIL receptor 2 specific antibody and its use
11/21/2007	CN101074260A Production of hygrophilous monospermous bacterium main-protective antigen univalent and multivalent vitelline antibody and use in aquatic animal
11/21/2007	CN101073668A Antibody compositions for selectively inhibiting vegf
11/21/2007	CN101073667A Enhancer for antibody to lymphocytic tumors
11/21/2007	CN100350040C Cell separation compositions methods
11/21/2007	CN100349920C Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours
11/21/2007	CN100349919C Monoclonal antibody and its preparing process and usage
11/21/2007	CN100349918C Method for preparing specific Immunoglobulin of cystvirus and adenovirus in respiratory tract
11/20/2007	US7297782 Nucleotide sequences coding modified fluorescent proteins for use as diagnostic indicator in hybridization and gene expression analysis; enhanced signaling probes
11/20/2007	US7297776 PRO1374 antibodies
11/20/2007	US7297775 Polypeptide variants
11/20/2007	US7297774 Isolated or purified mutated human fibroblast growth factor receptor-4 (FGFR-4) comprising point mutation resulting in replacement of glycine with arginine; tyrosine kinase inhibitors; anticarcinogenic agents
11/20/2007	US7297768 PRO3574 polypeptide
11/20/2007	US7297767 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
11/20/2007	US7297766 PRO5337 polypeptides
11/20/2007	US7297765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2007	US7297760 Cancer associated protein
11/20/2007	US7297509 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
11/20/2007	US7297500 Accuracte detection and classification of preferential meat proteins; obtain meat sample with monoclonal antibody, monitor binding, evaluate bonding profile
11/20/2007	US7297489 Mutations in and genomic structure of HERG—a long QT syndrome gene
11/20/2007	US7297487 Syrian hamster animal model for disease containing only the mutant desmin gene; Desmin gene of a Syrian hamster having a point mutation at the 571-position of the base sequence in the desmin cDNA translated region
11/20/2007	US7297336 Antihemophilic factor; therapy for blood coagulation disorders; antibodies; culture product
11/20/2007	US7297334 Anti-vegf antibodies
11/20/2007	CA2262409C Modified tie-2-receptor ligands
11/20/2007	CA2243943C Reagents for use as calibrators and controls
11/20/2007	CA2192455C Positive and positive/negative cell selection mediated by peptide release
11/20/2007	CA2177288C Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
11/20/2007	CA1341561C Manufacture and expression of large structural genes
11/15/2007	WO2007130455A2 Compositions and methods for treatment of non-hodgkins lymphoma
11/15/2007	WO2007130302A2 Rage fusion proteins, formulations, and methods of use thereof
11/15/2007	WO2007130031A1 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
11/15/2007	WO2007129895A2 Deimmunized antagonistic anti-human cd40 monoclonal antibody from the ch5d12 antibody
11/15/2007	WO2007129428A1 Method for isolation of stem cell
11/15/2007	WO2007128987A2 Therapy targeting cathepsin s
11/15/2007	WO2007128563A1 Antibody-targeted cytokines for therapy
11/15/2007	WO2007128557A1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody
11/15/2007	WO2007128553A2 Mig12
11/15/2007	WO2007128496A2 A group of esterases for the enantioselective production of fine and speciality chemicals
11/15/2007	WO2007128482A1 Use of a b-cell-depleting antibody for treatment of polyoma virus infections
11/15/2007	WO2007128231A1 Trail receptor-binding agents and uses of the same
11/15/2007	WO2007128136A1 A novel pilin glycoprotein from a group 4 pseudomonas aeruginosa strain
11/15/2007	WO2007128121A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007	WO2007110001A3 Chimeric proteins comprising matrilin 1 for therapeutic use
11/15/2007	WO2007085815A3 Ligands that bind il-4 and/or il-13
11/15/2007	WO2007084693A3 Immunoconjugates with improved efficacy for the treatment of diseases
11/15/2007	WO2007084692A3 Immunoconjugates for treatment of infectious diseases
11/15/2007	WO2007066236A3 Chimeric hiv-1 gp120 glycoproteins and their biological applications
11/15/2007	WO2007050798A3 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer
11/15/2007	WO2007047189A3 Targeted biocides
11/15/2007	WO2007030531A3 Reagents for testing and molecular imaging of liver cancer
11/15/2007	WO2007018556A3 Method for detection and decontamination of antigens by nanoparticle-raman spectroscopy
11/15/2007	WO2006138275A3 Compositions and methods for treating and diagnosing cancer
11/15/2007	WO2006088464A3 A method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection
11/15/2007	WO2005123780A3 Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis
11/15/2007	WO2005118878A3 Methods of screening for cell proliferation or neoplastic disorders
11/15/2007	WO2005100601A3 L-sign polymorphisms and methods involving use of same
11/15/2007	WO2005069906A3 Methods and compositions relating to vascular endothelial growth factor and th2 mediated inflammatory diseases
11/15/2007	WO2005021709A3 Cln101 antibodies
11/15/2007	WO2005017105A3 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450
11/15/2007	WO2003000840A3 Nitrilases
11/15/2007	WO2001055313A3 Nucleic acids, proteins, and antibodies
11/15/2007	US20070265436 Nucleotide sequences coding tumor-associated antigenic target polypeptide specific immunoglobulins for use in detection and prevention of cell proliferative disorders
11/15/2007	US20070265433 Process and Materials for the Rapid Detection of Streptococcus Pneumoniae Employing Purified Antigen-Specific Antibodies
11/15/2007	US20070265432 Multiplex-bead complex for determination of Lysosomal Storage Disorders
11/15/2007	US20070265198 Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof
11/15/2007	US20070264711 Human pellino polypeptides
11/15/2007	US20070264689 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
11/15/2007	US20070264686 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer treatment
11/15/2007	US20070264685 Polynucleotides encoding cytokine receptor
11/15/2007	US20070264668 Detecting O-acetylation of a serine or threonine residue of the substrate protein; post-translational modification of a predetermined protein expressed by a cell
11/15/2007	US20070264632 contacting the sample with a suicide substrate that covalently modifies a terpene synthase, results in covalent binding of the substrate to an amino acid of the enzyme to form a covalently modified enzyme; determining an amino acid sequence of at least a portion of the covalently modified enzyme
11/15/2007	US20070264624 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same
11/15/2007	US20070264277 Compositions and Methods of Use for Mgd-Csf in Disease Treatment
11/15/2007	US20070264276 Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases
11/15/2007	US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
11/15/2007	US20070264266 Maytansine derivatives having a sterically hindered thiol or disulfide groups, capable of conjugating to cell-binding agents, to form drugs having improved therapeutic efficacy in animal tumor models; antitumor agents
11/15/2007	US20070264263 Compositions for Inhibiting Sema7A and VLA-1 Interaction and the Methods of Using the Same
11/15/2007	US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007	US20070264260 Treatment methods using anti-CD22 antibodies

1 ... 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 ... 1494